Clinical Trials Logo

Low to Intermediate-1 MDS clinical trials

View clinical trials related to Low to Intermediate-1 MDS.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01736683 Completed - Anemia Clinical Trials

Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

Start date: November 28, 2012
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to determine a safe, tolerable and effective dose of sotatercept that results in the greatest frequency of improvement of anemia in patients diagnosed with low- or intermediate-1 risk myelodysplastic syndromes (MDS) or non-proliferative chronic myelomonocytic leukemia (CMML).